Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bio-Gene Technology Ltd. ( (AU:BGT) ) has provided an update.
Bio-Gene Technology Limited has successfully completed Tranche 2 of its share placement, raising approximately A$2.46 million. The placement, approved by shareholders, also included the issuance of unlisted options to investors and the lead manager. This financial move supports Bio-Gene’s strategic initiatives in the bio-insecticide market, enhancing its position in providing environmentally friendly pest control solutions.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Limited is an Australian company specializing in the development of novel bio-insecticides. These products aim to tackle global challenges related to insecticide resistance and toxicity, utilizing naturally occurring compounds that effectively control pests while minimizing harm to human health and the environment. The company’s offerings have diverse applications, including public health, crop protection, grain storage, and consumer use, providing innovative and safe pest management solutions.
Average Trading Volume: 249,678
Technical Sentiment Signal: Sell
Current Market Cap: A$4.8M
See more data about BGT stock on TipRanks’ Stock Analysis page.